ClinicalTrials.Veeva

Menu

Very Low Frequency Magnetic Fields Versus the Supplement "Xinepa" in the Treatment of the Carpal Tunnel Syndrome

U

University of Roma La Sapienza

Status

Completed

Conditions

Carpal Tunnel Syndrome

Treatments

Other: Placebo Xinepa®
Other: Xinepa®
Other: ELF

Study type

Interventional

Funder types

Other

Identifiers

NCT02891512
2545/15

Details and patient eligibility

About

The purpose of the study is to determine the effectiveness of the treatment with very low frequency magnetic fields (ELF) on the reduction of pain and the relief of the associated signs such as sensitivity disorders that affect the first three fingers and half of the fourth finger of the hand in patients with carpal tunnel syndrome versus the supplement (= Xinepa).

Enrollment

31 patients

Sex

All

Ages

20 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of carpal tunnel syndrome

Exclusion criteria

  • Pregnancy;
  • Pacemaker or other metallic implants;
  • Systemic infectious disorders;
  • Neoplastic disorders;
  • Epilepsy;
  • Severe heart disease.
  • Known hypersensitivity to the components of Xinepa

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

31 participants in 2 patient groups, including a placebo group

ELF and Xinepa®
Experimental group
Description:
The very low frequency magnetic fields (ELF) are magnetic fields already use for orthopedics pathology that have shown to be able to repair, to reduce pain, inflammation and edema in the damaged tissues. Xinepa® is a dietary supplement containing alpha-lipoic acid, N-acetyl-L-carnitine, turmeric, vitamins B, E and C. They have an antioxidant and anti-inflammatory action on nervous system and they act on cellular energy metabolism.
Treatment:
Other: ELF
Other: Xinepa®
ELF and Placebo Xinepa®
Placebo Comparator group
Description:
The very low frequency magnetic fields (ELF) are magnetic fields already use for orthopedics pathology that have shown to be able to repair, to reduce pain, inflammation and edema in the damaged tissues. Xinepa® without its specific activity for the condition being treated.
Treatment:
Other: ELF
Other: Placebo Xinepa®

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems